FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers identify a novel biomarker linked to renal cancer recurrence

2.

Older Adults With Advanced Cancer Prioritize Quality of Life

3.

Similar survival seen with simple versus radical hysterectomy for cervical cancer

4.

Interleukin-6 may boost prediction of obesity-related cancers

5.

Nasal therapeutic HPV vaccine could prevent cervical cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot